Cargando…

Therapeutic Inducers of Apoptosis in Ovarian Cancer

Ovarian cancers remain one of the most common causes of gynecologic cancer-related death in women worldwide. The standard treatment comprises platinum-based chemotherapy, and most tumors develop resistance to therapeutic drugs. One mechanism of developing drug resistance is alterations of molecules...

Descripción completa

Detalles Bibliográficos
Autores principales:	Binju, Mudra, Amaya-Padilla, Monica Angelica, Wan, Graeme, Gunosewoyo, Hendra, Suryo Rahmanto, Yohan, Yu, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896143/ https://www.ncbi.nlm.nih.gov/pubmed/31766284 http://dx.doi.org/10.3390/cancers11111786

Ejemplares similares

Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence
por: Padilla, Monica Angelica Amaya, et al.
Publicado: (2019)

Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?
por: Rendell, Aimee, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
por: Alsayed, Shahinda S. R., et al.
Publicado: (2023)

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer
por: Yu, Yu, et al.
Publicado: (2019)

TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells
por: Kim, Patrick Y., et al.
Publicado: (2013)

N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
por: Lane, Darius J. R., et al.
Publicado: (2013)

Correction: N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
por: Lane, Darius J. R., et al.
Publicado: (2016)

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2017)

Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
por: Yu, Yu, et al.
Publicado: (2018)

Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy
por: Shen, Yao-An, et al.
Publicado: (2021)

Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
por: Ayhan, Ayse, et al.
Publicado: (2015)

Siderocalin/Lcn2/NGAL/24p3 Does Not Drive Apoptosis Through Gentisic Acid Mediated Iron Withdrawal in Hematopoietic Cell Lines
por: Correnti, Colin, et al.
Publicado: (2012)

K63-linked ubiquitylation induces global sequestration of mitochondria
por: Richard, Thibaud J. C., et al.
Publicado: (2020)

Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
por: Mudra, Sarah E., et al.
Publicado: (2021)

Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
por: Martirosyan, Anna, et al.
Publicado: (2010)

Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors
por: Shi, Ying, et al.
Publicado: (2018)

Scope of nanotechnology in ovarian cancer therapeutics
por: Yallapu, Murali M, et al.
Publicado: (2010)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

Development of Therapeutic Vaccines for Ovarian Cancer
por: Chow, Stephanie, et al.
Publicado: (2020)

STAT3 signaling in ovarian cancer: a potential therapeutic target
por: Liang, Renba, et al.
Publicado: (2020)

Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis
por: Cao, Chao, et al.
Publicado: (2019)

Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
por: Shen, Jiayu, et al.
Publicado: (2018)

Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents
por: Alsayed, Shahinda S. R., et al.
Publicado: (2020)

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
por: Suryo Rahmanto, Yohan, et al.
Publicado: (2020)

Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia
por: Shi, Jun-Jie, et al.
Publicado: (2021)

Therapeutic Targeting of Collective Invasion in Ovarian Cancer
por: Moffitt, Laura, et al.
Publicado: (2019)

Apoptosis pathways and their therapeutic exploitation in pancreatic cancer
por: Fulda, Simone
Publicado: (2009)

Garcinone E induces apoptosis and inhibits migration and invasion in ovarian cancer cells
por: Xu, Xiao-Huang, et al.
Publicado: (2017)

Overactivation or Apoptosis: Which Mechanisms Affect Chemotherapy-Induced Ovarian Reserve Depletion?
por: Kashi, Oren, et al.
Publicado: (2023)

Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020)

Therapeutic Prospects of Polysaccharides for Ovarian Cancer
por: Wang, Kaili, et al.
Publicado: (2022)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
por: Alexandrova, Elena, et al.
Publicado: (2020)

Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications
por: Yoon, Hyunho, et al.
Publicado: (2022)

Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
por: Yang, Wookyeom, et al.
Publicado: (2021)

Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas
Publicado: (1981)

Engineered nanoparticles induce cell apoptosis: potential for cancer therapy
por: Ma, Dan-Dan, et al.
Publicado: (2016)

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
por: Brunner, Andrä, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gjijhjc87sku398ir5ga3ba4mi